ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,234, issued on Sept. 8, was assigned to Voyager Therapeutics Inc. (Lexington, Mass.).

"Tau binding compounds" was invented by Vinodhbabu Kurella (Cambridge, Mass.), Li Liu (Cambridge, Mass.), Dillon Kavanagh (Cambridge, Mass.), Allan D. Capili (Somerville, Mass.), Jinzhao Hou (Lexington, Mass.), Todd Carter (Cambridge, Mass.) and Wencheng Liu (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides anti-tau antibodies. Also provided are methods of using anti-tau antibodies for treatment and diagnosis of neurological indications."

The patent was filed on Dec. 15, 2021, under Application No. 18/267,711.

*For f...